Maqui Berry Extract.

Ascorbate donates an electron back to anthocyanin radicals formed after they quench an oxidant, returning them to the active form. The two also co-occur naturally in berry matrices, which is why they are formulated together.

Both deliver cyanidin and delphinidin glycosides that share absorption routes and gut microbial conversion to phenolic acids. Blending widens the anthocyanin profile rather than adding a new mechanism.

Bilberry is rich in cyanidin and malvidin glycosides where maqui is dominated by delphinidins. The mix broadens which anthocyanin aglycones reach circulation and the colon.

Quercetin and anthocyanins are both handled by intestinal and hepatic glucuronidation and sulfation, and can spare one another at those enzymes. They also quench different oxidant species in the membrane and aqueous phases.

Proanthocyanidins co-pigment with anthocyanins, which stabilises the coloured form and slows degradation in the product and the gut. The pairing is long-standing in berry polyphenol formulas.

Berry polyphenols and tannins bind ferric iron in the gut lumen and form complexes that are poorly taken up. Taking a maqui extract at the same meal as a non-heme iron dose lowers how much of that iron is absorbed, so separate them by a couple of hours.

Milk proteins bind anthocyanins through hydrogen bonding and hydrophobic contact, which slows their release and can lower measured plasma appearance. It matters when a berry extract is blended straight into a protein powder.

Lutein accumulates in the macula and quenches singlet oxygen there, while maqui anthocyanins act mainly in circulation and in the ocular surface tissues. The two occupy different compartments, so the pairing is complementary rather than duplicative. Neither has been shown to change the other's tissue level in people.

Zeaxanthin concentrates in the central macula and handles high-energy light, a role no anthocyanin performs. Maqui delphinidin glycosides are cleared quickly and do not accumulate in retinal tissue. Combining them covers two separate mechanisms in eye-focused formulas.

Astaxanthin is a lipid-phase carotenoid that spans membranes, while anthocyanins are water soluble and act in the aqueous phase. Radical handling in the two phases is not interchangeable. This is mechanistic complementarity, not a demonstrated combined outcome.

Tocopherol radicals formed in membranes are reduced back by water-phase reductants at the membrane interface, the same chemistry that links vitamin E with vitamin C. Polyphenols including anthocyanins participate in that interfacial recycling in laboratory systems. Whether it matters at supplement doses in people has not been established.

Alpha-lipoic acid works in both water and lipid phases and feeds the glutathione and ascorbate pools. Anthocyanin metabolites are short-lived in circulation and depend on those pools to remain in a reduced state. Direct combination data is not available.

Both are plant polyphenols that undergo heavy phase two conjugation in the gut wall and liver, so both circulate mostly as glucuronides and sulfates. They compete for the same conjugating enzymes at high intakes, which can raise or lower each other's free fraction. The direction of that shift at normal supplement doses has not been measured.

Pterostilbene is methylated and therefore less conjugated than resveratrol, so it survives first pass better than most anthocyanins do. Pairing a well-absorbed stilbene with a poorly absorbed anthocyanin gives two different exposure profiles from one serving. There is no combination study behind this pairing.

Elderberry is rich in cyanidin glycosides, maqui in delphinidin glycosides, and the two aglycones differ in hydroxylation and therefore in stability and colour across pH. Blending them widens the anthocyanin profile of a formula. Total anthocyanin content should be stated per source rather than pooled into one number.

Catechins and anthocyanins are both substrates for catechol-O-methyltransferase and for UDP-glucuronosyltransferases, so co-dosing loads the same clearance enzymes. That can extend or shorten circulating metabolite exposure depending on which pathway saturates. Flag it as competition for shared metabolism, not as a lost effect.

Piperine inhibits intestinal and hepatic glucuronidation and raises circulating levels of several poorly absorbed plant compounds. Anthocyanins are heavily glucuronidated, so the mechanism is applicable in principle. No published work shows piperine raising maqui anthocyanin exposure, so this stays a mechanistic proposal.

Most ingested anthocyanin passes to the colon, where bacteria cleave the sugar and split the ring into phenolic acids such as protocatechuic and gallic acid, which are then absorbed. The bacterial community present determines which metabolites appear. Whether a delivered strain changes that metabolite profile in people has not been established.

A fermentable fibre feeds the same colonic bacteria that convert anthocyanin glycosides into absorbable phenolic acids. Pairing fibre with a berry extract targets the conversion step rather than the parent compound. This is a mechanistic rationale; combined human metabolite data is lacking.

Milk proteins bind anthocyanins through hydrogen bonding and hydrophobic contacts, which is why berry colour dulls in a dairy matrix. Bound anthocyanin is less available for immediate absorption, though the complex can dissociate during digestion. Formulating a berry extract into a milk-protein base is a real exposure variable to describe.

Both maqui extract and cinnamon have been studied for effects on post-meal glucose readings, so stacking them can push the same marker in the same direction. Glucose readings are markers, not outcomes. Anyone already using glucose-lowering medication should have that combination supervised.

Berberine has a well-documented effect on fasting and post-meal glucose readings, and maqui extract has been reported to lower glucose readings in adults with high blood sugar. Combining them adds two glucose-directed inputs. Flag this as an additive effect to monitor, not as a stronger benefit.

Gymnema is used for glucose-directed formulas and would stack with maqui extract on the same marker. The combination has not been trialled together. Additive direction on a marker is the honest description here.

Chromium is discussed in relation to insulin signalling and is a common component of glucose-support formulas. Adding it alongside maqui extract points two ingredients at the same readings. Effects here are on measured glucose and insulin markers rather than on any clinical endpoint.

EPA and DHA are incorporated into membrane phospholipids, including those of ocular surface tissue, while anthocyanins act transiently through circulating metabolites. The two mechanisms do not overlap. No study has tested the pair together.

Hyaluronic acid holds water at a surface by physical hydration, a mechanism entirely unlike polyphenol redox chemistry. Formulas aimed at tear film comfort often carry both. The pairing rests on distinct mechanisms rather than on a combined trial.